期刊文献+

日本蛇菰中咖啡酰基葡萄糖类化合物抑制HIV-1进入的机制 被引量:5

Study of the mechanism of caffeoyl glucopyranoses in inhibiting HIV-1 entry using pseudotyped virus system
下载PDF
导出
摘要 目的研究从日本蛇菰中分离的咖啡酰基葡萄糖类化合物抑制HIV-1进入的作用机制。方法利用HIV-1假病毒体系,并结合针对gp41包膜蛋白的ELISA以及分子对接方法,对日本蛇菰分离的咖啡酰基葡萄糖类化合物抑制HIV-1进入机制进行研究。结果我们首先用HIV-1 Env假病毒来检测六个咖啡酰基葡萄糖类化合物(终浓度:25μg·ml-1)的抑制活性,发现1,2,6-三-O-咖啡酰基-β-D-吡喃葡萄糖(TCGP)和1,3-双-O-咖啡酰基-4-O-没食子酰-β-D-吡喃葡萄糖(DCGGP)具有较好的抑制病毒进入靶细胞的作用。进一步量效关系研究表明,两个化合物的病毒抑制活性呈剂量依赖性,它们的IC50值分别是(5.5±0.2)和(5.3±0.1)μg·ml-1。这两个化合物的抑制活性与其抑制gp41六螺旋束结构形成的机制有关。分子对接表明,它们均能靶向gp41上N-螺旋三聚体的靶穴位置。结论1,2,6-三-O-咖啡酰基-β-D-吡喃葡萄糖(TCGP)和1,3-双-O-咖啡酰基-4-O-没食子酰-β-D-吡喃葡萄糖(DCGGP)可以较好的抑制HIV-1 Env假病毒感染靶细胞,可作为先导化合物来研发抗HIV-1新药。 Objective To investigate the inhibitory activities of caffeoyl glucopyranoses purified from Balanophora japonica Makino on HIV entry and their mechanism.Methods HIV-1 Env pseudovirus was used to evaluate the anti-HIV-1 activity of those compounds.ELISA and molecular docking were used to study the mechanism of the actions of the active compounds.Results We used the HIV-1 Env pseudovirus to test the anti-HIV-1 activity of the six phenolic compounds (final concentration 25 μg/ml),and found that only 1,2,6-Tri-O-caffeoyl-β-D-glucopyranose (TCGP) and 1,3-Di-O-caffeoyl-4-O-galloyl-β-D- glucopyranose (DCGGP) could effectively inhibit the entry of HIV-1 Env pseudovirus into the target cells in a dose-dependent manner,with IC50 values of 5.5±0.2 and 5.3±0.1 μg/ml,respectively.These two compounds could also blocked the gp41 six-helix bundle formation.Molecular docking analysis suggested that they might bind to the hydrophobic cavity of the gp41 N-trimeric coiled-coil.Conclusion TCGP and DCGGP are potent HIV-1 entry inhibitors targeting gp41 and can serve as lead compounds for developing novel anti-HIV-1 microbicides for prevention of sexual HIV-1 transmission.
出处 《南方医科大学学报》 CAS CSCD 北大核心 2010年第4期720-723,共4页 Journal of Southern Medical University
基金 国家自然科学基金(30729001和U0832001) 广州市科技计划项目(2007J1-C0251)
关键词 HIV-1gp41 咖啡酰基葡萄糖类化合物 假病毒 HIV-1进入抑制剂 HIV-1 gp41 caffeoyl glucopyranoses pseudovirus HIV entry inhibitors
  • 相关文献

参考文献9

  • 1刘叔文,李卫华,丁训诚,姜世勃.预防HIV性传播的杀微生物剂[J].中国计划生育学杂志,2008,16(5):317-320. 被引量:12
  • 2de Clercq E. Antiviral drugs in current clinical use[J]. J Clin Virol, 2004, 30(2): 115-33.
  • 3孙魏,王洪涛,夏承来,吴曙光,姜世勃,姜志宏,刘叔文.三没食子酰吡喃葡糖作用于gp41抑制HIV与靶细胞的融合[J].南方医科大学学报,2008,28(7):1127-1131. 被引量:6
  • 4Jiang ZH, Hirose Y, Iwata H, et al. Caffeoyl, coumaroyl, galloyl, and hexahydroxydiphenoyl glucoses from Balanophora japonica [J]. Chem Pharm Bull (Tokyo), 2001, 49(7): 887-92.
  • 5Jiang Z H, Tanaka T, Iwata H, et al. Ellagitannins and lignan glycosides from Balanophora japonica (Balanophoraceae) [ J ]. Chem Pharm Bull (Tokyo), 2005, 53(3): 339-41.
  • 6Heyndrickx L, Vermoesen T, Vereecken K, et al. Antiviral compounds show enhanced activity in HIV-1 single cycle pseudovirus assays as compared to classical PBMC assays [J]. J Virol Methods, 2008, 148(1-2): 166-73.
  • 7Liu S, Jing W, Cheung B, et al. HIV gp41 C-terminal heptad repeat contains multifunctional domains. Relation to mechanisms of action of anti-HIV peptides [ J ]. J Biol Chem, 2007, 282(13): 9612-20.
  • 8Lee JS, Kim HJ, Lee YS. A new anti-HIV flavonoid glucuronide from Chrysanthemum morifolium [J]. Planta Med, 2003, 69(9): 859-61.
  • 9Gupta S P, Nagappa A N. Design and development of integrase inhibitors as anti-HIV agents. [J]. Curr Med Chem, 2003, 10(18): 1779-94.

二级参考文献28

  • 1刘叔文,吴曙光,姜世勃.新型抗艾滋病药物——HIV进入抑制剂的研究进展[J].中国药理学通报,2005,21(9):1034-1040. 被引量:19
  • 2Klasse PJ, Shattock R, Moore JP. Antiretroviral Drug - Based Microbicides to Prevent HIV - 1 Sexual Transmission. Annu Rev Med, 2008, 59:455 -471.
  • 3Shattock R J, Moore JP. Inhibiting sexual transmission of HIV - 1 infection. Nat Rev Microbiol, 2003, 1 : 25 - 34.
  • 4Stone A. Microbicides: a new approach to preventing HIV and other sexually transmitted infections. Nat Rev Drug Discov, 2002, 1 : 977 - 985.
  • 5Hillier SL, Moench T, Shattock R, et al. In vitro and in vivo: the story of nonoxynol 9. J Acquir Immune Defic Syndr, 2005,39 ( 1 ) : 1 - 8.
  • 6Balzarini J, Van Damme L. Microbicide drug candidates to prevent HIV infection.Lancet, 2007, 369:787 -797.
  • 7Stone A, Jiang S. Microbicides: stopping HIV at the gate. Lancet, 2006, 368:431 -433.
  • 8van de Wijgert JH, Shattock RJ. Vaginal microbicides: moving ahead after an unexpected setback. AIDS, 2007, 21 (18) : 2369 -2376.
  • 9Veazey RS, Klasse PJ, Schader S, et al. Protection of macaques from vaginal SHIV challenge by vaginally delivered inhibitors of virus - cell fusion. Nature, 2005, 438:99-102.
  • 10Margolis L, Shattock R. Selective transmission of CCR5 - utilizing HIV-1: the 'gatekeeper'problem resolved? Nat Rev Microbiol, 2006, 4: 312 -317.

共引文献16

同被引文献49

引证文献5

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部